MedTrace Logo

A Study of Technology to Improve Glucose Control in Participants With Type 1 Diabetes

NCT03758430 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2020-08-21

No results posted yet for this study

Summary

The main purpose of this study is to determine whether combining meal, glucose, and insulin data in a web-based system will improve management of type 1 diabetes (T1D). No study drug will be given. The study will last about 18 weeks.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

OTHER

Meal-Tagging App

Meal tagging app to capture frequently eaten meals and test meals for 16 weeks.

DEVICE

Fitness Tracker

Fitness tracker will be worn around the clock for 16 weeks.

Sponsors & Collaborators

Principal Investigators

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) · Eli Lilly and Company

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-06
Primary Completion
2020-08-07
Completion
2020-08-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03758430 on ClinicalTrials.gov